| Entry |
|
|---|
| Name |
Denintuzumab mafodotin (USAN/INN) |
|---|
| Efficacy |
Antineoplastic |
|---|
| Type |
Antibody-drug conjugate |
|---|
| Comment |
Treatment of B-cell malignancies
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04662 | B cell receptor signaling pathway |
|
|---|
| Brite |
Target-based classification of drugs [BR:br08310]
Cell surface molecules and ligands
Other cell surface molecules
CD molecules
CD19
D11232 Denintuzumab mafodotin (USAN/INN)
Not elsewhere classified
Cellular process
Cytoskeleton
TUBB
D11232 Denintuzumab mafodotin (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
